COVID-19 Outcomes in Critically Ill No Better With Full-Dose Heparin
For patients hospitalized with COVID-19 who are not critically ill, therapeutic-dose anticoagulation is beneficial
Text Reminders Boost COVID-19 Vaccine Appointments
Messages that stress the accessibility of the vaccine and include 'ownership' language most effective
Almost Half of Pediatric Opioid Prescriptions Considered High-Risk
61.4 percent of the prescriptions written by dentists, surgeons; high-volume prescribers wrote more than half of prescriptions
Vitamin K Inversely Linked to Risk for Atherosclerotic CVD
Participants with diets high in vitamin K1 and vitamin K2 have reduced risk for atherosclerotic CVD in adjusted analyses
Dexamethasone Underused for Adults Hospitalized With COVID-19
Dexamethasone and remdesivir use have gradually increased during the pandemic; hydroxychloroquine use peaked in March 2020
Exposure to Prenatal Antipsychotics Seems Safe
No increased risk seen for ADHD, ASD, small for gestational age with prenatal antipsychotics exposure
Canada to Mandate COVID-19 Vaccines for All Plane, Train Travelers
More than 71 percent of eligible Canadians are fully vaccinated, and 82 percent have had at least their first shot
Third Dose of mRNA-1273 Boosts Immunity in Transplant Recipients
More patients receiving mRNA-1273 booster have serologic response with anti-receptor-binding domain antibody level of at least 100 U/mL
FDA OKs Third COVID-19 Shot for Vulnerable Americans
Authorization includes people who have had solid organ transplants and those whose immune systems are equally compromised
